Spectrum Pharmaceuticals News

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia HENDERSON, Nev.-- --Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and ... (more)

Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology , today announced the initiation of patient enrollment in a Phase 1 clinical trial evaluating the safety and tolerability of RenaZorbA in healthy volunteers.

Pharmaceuticals, Inc. and Allos Therapeutics, Inc. today announced that Spectrum has provided an additional extension of the offer period in connection with its tender offer to purchase all of the outstanding shares of common stock of Allos for $1.82 per share in cash, without interest and less any applicable withholding taxes, plus one Contingent ... (more)

's stock had its "buy" rating reiterated by equities research analysts at Auriga in a research note issued to investors on Thursday.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Spectrum Pharmaceuticals, Inc.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Spectrum Pharmaceuticals, Inc.

Biotechnology company Spectrum Pharmaceuticals has announced that it has increased the company's manufacturing capacity for Fusilev for injection in order to meet the demand needs of the US patient population and prevent the kinds of shortages currently plaguing the US drug market.

HENDERSON, Nev. -- -- Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an overview of the Company's business strategy will be given at the Bank of America Merrill Lynch 2012 Health Care Conference being held at ... (more)

's stock had its "outperform" rating restated by Zacks in a research report issued to clients and investors on Monday.

Examining the regulatory filings of successful hedge funds can often give investors valuable insight into the thinking of top investment managers.

HOW WE DID IT Companies based in Las Vegas were considered. The only exception was Molycorp, based in Greenwood Village, Colo., but with nearly all operations at a mine near Primm.

SPPI -0.8% ALTH +0% BIIB -2.47% AGN -0.79% BMY -0.39% GSK -1.71% ENDP -1.17% BDSI -1.3% The National Cancer Institute estimates in its Cancer Statistics Review that over 1.5 million individuals will be diagnosed with cancer in 2012.

Today they are providing members comprehensive research on the Biotechnology industry and are offering free analytical research on Spectrum Pharmaceuticals Inc.

The company also develops therapeutic for non-cancer diseases such as Acne, XLHED and Gout.

Spectrum Pharmaceuticals has always been one of my favorite options in the biotech industry and it has lately begun getting attention from some of the experts.

HENDERSON, Nev. -- -- Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an overview of the Company's business strategy will be given at the 37th Annual Deutsche Bank Health Care Conference being held at The ... (more)

Spectrum Pharmaceuticals may be working its way back into the game with its intention to increase the manufacturing capacity of Fusilev.